切换导航
关闭
  • 菜单
  • Setting

Signaling Pathways - haspin kinase - Inward Rectifier Potassium (Kir) Channels - Angiotensin AT1 Receptors

11件产品中的 1-10

页面
每页
清除全部
  1. LDN 209929 dihydrochloride
    B7785 LDN 209929 dihydrochloride
    Target: haspin kinase
    Summary: Haspin激酶抑制剂
      <40.58 mg/mL
      <40.58 mg/mL
  2. Nateglinide
    B2198 Nateglinide
    中文名: 那格列奈
    Target: Inward Rectifier Potassium (Kir) Channels
    Summary: 胰岛素促分泌剂
      ≥16.4 mg/mL
      insoluble in H2O
  3. Gliclazide
    B2195 Gliclazide
    中文名: 格列齐特
    Target: Inward Rectifier Potassium (Kir) Channels
    Summary: 钾通道抑制剂
      ≥15.6 mg/mL
      insoluble in H2O
  4. Valsartan
    B2214 Valsartan
    中文名: 缬沙坦
    Target: Angiotensin AT1 Receptors
    Summary: 血管紧张素II AT1受体拮抗剂
      ≥19.65 mg/mL
      insoluble in H2O
  5. Mitiglinide Calcium
    B2193 Mitiglinide Calcium
    中文名: 米格列奈钙
    Target: Inward Rectifier Potassium (Kir) Channels
    Summary: 钾通道抑制剂
      ≥33.45 mg/mL
      insoluble in H2O
  6. AVE 0991
    B1007 AVE 0991
     1 Citation
    Target: Angiotensin AT1 Receptors
    Summary: 血管紧张素-(1-7)受体激动剂
      ≥29.04 mg/mL
  7. Glibenclamide
    B1296 Glibenclamide
    中文名: 格列本脲
    Target: Inward Rectifier Potassium (Kir) Channels
    Summary: 胰岛素生产调节剂
      ≥49.4 mg/mL
      insoluble in H2O
  8. Azilsartan
    B2210 Azilsartan
    中文名: 阿齐沙坦
    Target: Angiotensin AT1 Receptors
    Summary: 强效血管紧张素II 1型(AT1)受体反向激动剂
      ≥16.95 mg/mL
      insoluble in H2O
  9. Terfenadine
    A8534 Terfenadine
    中文名: 特非那定
    Target: Voltage-gated Potassium (KV) Channels|Histamine H1 Receptors|Inward Rectifier Potassium (Kir) Channels
    Summary: 组胺H1受体拮抗剂
      ≥18 mg/mL
      insoluble in H2O
  10. Irbesartan
    A5970 Irbesartan
    中文名: 安博维,厄贝沙坦
    Target: Angiotensin AT1 Receptors
    Summary: 血管紧张素II抑制剂
      ≥17.4 mg/mL
      insoluble in H2O

11件产品中的 1-10

页面
每页